Thousands Are Ditching Inhalers and Breathing Easier with This Surprising Lung Supplement Backed by Nature and ScienceJUPITER, FLORIDA, Apr ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Discover why Immutep's Eftilagimod Alpha shows promise in NSCLC and HNSCC trials, but cautious investment is advised. Explore more details here.

Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for administration of the drug to patients.

Cinnamon tea is a source of antioxidants and may bring various health benefits. Learn how to make it and possible side ...

Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the ...

The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion in 2024 and an impressive US$1.30 billion by 2030. The key ...

The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion ...

Out of the Void curates the entire back catalogue of the record label’s releases. The limited edition book is a time capsule ...